PH12013500142A1 - Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition - Google Patents
Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or conditionInfo
- Publication number
- PH12013500142A1 PH12013500142A1 PH1/2013/500142A PH12013500142A PH12013500142A1 PH 12013500142 A1 PH12013500142 A1 PH 12013500142A1 PH 12013500142 A PH12013500142 A PH 12013500142A PH 12013500142 A1 PH12013500142 A1 PH 12013500142A1
- Authority
- PH
- Philippines
- Prior art keywords
- pharmaceutical composition
- condition
- methods
- conditions associated
- treating diseases
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- 101800004538 Bradykinin Proteins 0.000 abstract 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 abstract 1
- 102100035792 Kininogen-1 Human genes 0.000 abstract 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 abstract 1
- 229960001340 histamine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010130352/15A RU2528093C2 (ru) | 2010-07-21 | 2010-07-21 | Фармацевтическая композиция и способ лечения острых и хронических заболевания дыхательной системы и синдрома кашля |
| RU2011125992/15A RU2529783C2 (ru) | 2011-06-24 | 2011-06-24 | Лекарственное средство для лечения патологического синдрома и способ лечения острых и хронических заболеваний дыхательноый системы и синдрома кашля |
| PCT/IB2011/002346 WO2012010973A2 (en) | 2010-07-21 | 2011-07-15 | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12013500142A1 true PH12013500142A1 (en) | 2013-03-11 |
Family
ID=44899162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2013/500142A PH12013500142A1 (en) | 2010-07-21 | 2011-07-15 | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8795657B2 (enExample) |
| EP (1) | EP2595655A2 (enExample) |
| JP (2) | JP2013533269A (enExample) |
| CN (1) | CN103200964A (enExample) |
| AR (1) | AR082313A1 (enExample) |
| AU (1) | AU2011281247B2 (enExample) |
| BR (1) | BR112013001297A2 (enExample) |
| CA (1) | CA2805978C (enExample) |
| CL (1) | CL2013000202A1 (enExample) |
| DE (1) | DE112011102412T5 (enExample) |
| EA (1) | EA029228B1 (enExample) |
| ES (1) | ES2425315R1 (enExample) |
| FR (1) | FR2962909A1 (enExample) |
| GB (1) | GB2496800B (enExample) |
| IT (1) | ITTO20110638A1 (enExample) |
| MX (1) | MX356678B (enExample) |
| MY (1) | MY158522A (enExample) |
| NZ (1) | NZ606977A (enExample) |
| PE (1) | PE20130387A1 (enExample) |
| PH (1) | PH12013500142A1 (enExample) |
| SG (1) | SG187579A1 (enExample) |
| WO (1) | WO2012010973A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| WO2012017324A2 (en) | 2010-07-15 | 2012-02-09 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| PH12013500107A1 (en) | 2010-07-15 | 2013-03-11 | Oleg Iliich Epshtein | A method of increasing the effect of an activated-potentiated form of an antibody |
| PH12013500144A1 (en) | 2010-07-21 | 2018-03-21 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| JP2013533269A (ja) * | 2010-07-21 | 2013-08-22 | イリイチ・エプシテイン オレグ | 組み合わせ医薬組成物及び呼吸器の疾患又は状態に関連する疾患及び状態を治療する方法 |
| CZ2013124A3 (cs) * | 2010-07-21 | 2013-06-12 | Iliich Epshtein@Oleg | Kombinovaná farmaceutická kompozice a zpusoby lécby diabetu a metabolických chorob |
| ITTO20110630A1 (it) * | 2010-07-21 | 2012-01-22 | Oleg Iliich Epshtein | Composizioni farmaceutiche di combinazione e metodo per trattare vertigini, cinetosi e distonia vascolare vegetativa |
| PE20131185A1 (es) * | 2010-08-06 | 2013-10-05 | Materia Medica Holding | Composicion farmaceutica combinada y metodos para el tratamiento y prevencion de las enfermedades infecciosas |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| DE102020007979A1 (de) | 2020-12-29 | 2022-06-30 | Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie | Zusammensetzung zur Behandlung von lnfektionen mit Coronaviren |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| US5741488A (en) | 1992-10-08 | 1998-04-21 | The Kennedy Institute For Rheumatology | Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies |
| IT1261849B (it) | 1993-09-02 | 1996-06-03 | Avantgarde Spa | Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. |
| US5629286A (en) | 1994-03-31 | 1997-05-13 | Brewitt; Barbara | Homeopathic dilutions of growth factors |
| IL110035A0 (en) | 1994-06-16 | 1994-10-07 | Tapuach Natural Technologies 1 | Homeopathic formulations |
| EP0884042A4 (en) | 1996-02-12 | 2006-01-04 | Oleg Iliich Epshtein | MEDICAMENT AND METHOD FOR TREATING AN ORGANISM WITH THIS |
| US5834443A (en) * | 1996-05-21 | 1998-11-10 | Masiello; Domenick J. | Composition and method for treating herpes simplex |
| RU2114646C1 (ru) | 1996-09-30 | 1998-07-10 | Олег Ильич Эпштейн | Способ повышения защитных свойств организма при воздействии внешних физических факторов |
| RU2103999C1 (ru) | 1997-01-31 | 1998-02-10 | Олег Ильич Эпштейн | Способ лечения алкоголизма |
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2199244C2 (ru) * | 2000-10-05 | 2003-02-27 | Самофалова Лариса Александровна | Способ получения пищевой муки масличных семян |
| RU2191602C1 (ru) | 2001-06-01 | 2002-10-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций |
| RU2197266C1 (ru) | 2001-06-01 | 2003-01-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения эрозивных и воспалительных заболеваний желудочно-кишечного тракта |
| RU2206338C1 (ru) | 2001-12-07 | 2003-06-20 | Эпштейн Олег Ильич | Способ лечения синдрома кашля |
| RU2199344C1 (ru) | 2001-12-07 | 2003-02-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения синдрома кашля |
| RU2201255C1 (ru) | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
| RU2199345C1 (ru) | 2001-12-26 | 2003-02-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции углеводного и жирового обмена |
| RU2209083C1 (ru) | 2001-12-26 | 2003-07-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения кашля |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| UA76639C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| WO2004082597A2 (en) | 2003-03-14 | 2004-09-30 | Nutrition Research, Inc. | Homeopathic formulations useful for treating pain and/or inflammmation |
| RU2253478C1 (ru) | 2003-10-01 | 2005-06-10 | Эпштейн Олег Ильич | Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества |
| MX2008015621A (es) * | 2006-06-06 | 2009-03-06 | Oleg Iliich Epshtein | Agente medicinal para el tratamiento de obesidad, diabetes y enfermedades relacionadas con la tolerancia deteriorada de glucosa. |
| CN102014939A (zh) * | 2008-04-29 | 2011-04-13 | 贡万特·德维昌德·奥斯瓦尔 | 顺势疗法配方产品 |
| WO2012017324A2 (en) | 2010-07-15 | 2012-02-09 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| NZ606775A (en) | 2010-07-15 | 2015-08-28 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating genitourinary system disorders |
| MX2013000542A (es) | 2010-07-15 | 2013-06-28 | Oleg Iliich Epshtein | Composicion farmaceutica combinada y metodos para el tratamiento de las enfermedades o condiciones funcionales del tracto gastrointestinal. |
| CA2805091A1 (en) * | 2010-07-15 | 2012-01-19 | Oleg Iliich Epshtein | Pharmaceutical compositions comprising a homopathically potentized form of an antibody to human cannabinoid receptor |
| CZ2013124A3 (cs) * | 2010-07-21 | 2013-06-12 | Iliich Epshtein@Oleg | Kombinovaná farmaceutická kompozice a zpusoby lécby diabetu a metabolických chorob |
| ITTO20110630A1 (it) * | 2010-07-21 | 2012-01-22 | Oleg Iliich Epshtein | Composizioni farmaceutiche di combinazione e metodo per trattare vertigini, cinetosi e distonia vascolare vegetativa |
| JP2013533269A (ja) * | 2010-07-21 | 2013-08-22 | イリイチ・エプシテイン オレグ | 組み合わせ医薬組成物及び呼吸器の疾患又は状態に関連する疾患及び状態を治療する方法 |
| PE20131185A1 (es) | 2010-08-06 | 2013-10-05 | Materia Medica Holding | Composicion farmaceutica combinada y metodos para el tratamiento y prevencion de las enfermedades infecciosas |
-
2011
- 2011-07-15 JP JP2013520239A patent/JP2013533269A/ja active Pending
- 2011-07-15 FR FR1156475A patent/FR2962909A1/fr not_active Withdrawn
- 2011-07-15 WO PCT/IB2011/002346 patent/WO2012010973A2/en not_active Ceased
- 2011-07-15 EA EA201300131A patent/EA029228B1/ru not_active IP Right Cessation
- 2011-07-15 US US13/135,884 patent/US8795657B2/en active Active
- 2011-07-15 AU AU2011281247A patent/AU2011281247B2/en not_active Ceased
- 2011-07-15 CN CN2011800455711A patent/CN103200964A/zh active Pending
- 2011-07-15 EP EP11778681.4A patent/EP2595655A2/en not_active Ceased
- 2011-07-15 BR BR112013001297A patent/BR112013001297A2/pt not_active Application Discontinuation
- 2011-07-15 NZ NZ606977A patent/NZ606977A/en not_active IP Right Cessation
- 2011-07-15 DE DE112011102412T patent/DE112011102412T5/de not_active Withdrawn
- 2011-07-15 MX MX2013000806A patent/MX356678B/es active IP Right Grant
- 2011-07-15 MY MYPI2013000232A patent/MY158522A/en unknown
- 2011-07-15 ES ES201390008A patent/ES2425315R1/es active Pending
- 2011-07-15 GB GB1302926.9A patent/GB2496800B/en not_active Expired - Fee Related
- 2011-07-15 SG SG2013004825A patent/SG187579A1/en unknown
- 2011-07-15 IT IT000638A patent/ITTO20110638A1/it unknown
- 2011-07-15 CA CA2805978A patent/CA2805978C/en not_active Expired - Fee Related
- 2011-07-15 PH PH1/2013/500142A patent/PH12013500142A1/en unknown
- 2011-07-15 PE PE2013000107A patent/PE20130387A1/es not_active Application Discontinuation
- 2011-07-21 AR ARP110102643A patent/AR082313A1/es unknown
-
2013
- 2013-01-21 CL CL2013000202A patent/CL2013000202A1/es unknown
-
2014
- 2014-07-11 US US14/328,792 patent/US20150023985A1/en not_active Abandoned
-
2016
- 2016-07-01 JP JP2016131753A patent/JP2016216479A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20150023985A1 (en) | 2015-01-22 |
| AU2011281247B2 (en) | 2015-07-30 |
| CL2013000202A1 (es) | 2015-01-16 |
| EP2595655A2 (en) | 2013-05-29 |
| GB2496800B (en) | 2018-05-23 |
| WO2012010973A2 (en) | 2012-01-26 |
| MY158522A (en) | 2016-10-14 |
| SG187579A1 (en) | 2013-03-28 |
| US20120225074A1 (en) | 2012-09-06 |
| ES2425315R1 (es) | 2014-09-08 |
| EA201300131A1 (ru) | 2013-11-29 |
| CA2805978A1 (en) | 2012-01-26 |
| GB201302926D0 (en) | 2013-04-03 |
| DE112011102412T5 (de) | 2013-07-04 |
| MX2013000806A (es) | 2013-10-28 |
| PE20130387A1 (es) | 2013-03-30 |
| EA029228B1 (ru) | 2018-02-28 |
| GB2496800A (en) | 2013-05-22 |
| WO2012010973A3 (en) | 2012-04-26 |
| ES2425315A2 (es) | 2013-10-14 |
| FR2962909A1 (fr) | 2012-01-27 |
| US8795657B2 (en) | 2014-08-05 |
| CA2805978C (en) | 2016-06-28 |
| CN103200964A (zh) | 2013-07-10 |
| MX356678B (es) | 2018-06-08 |
| AU2011281247A1 (en) | 2013-03-14 |
| JP2016216479A (ja) | 2016-12-22 |
| BR112013001297A2 (pt) | 2017-11-21 |
| NZ606977A (en) | 2015-08-28 |
| AR082313A1 (es) | 2012-11-28 |
| ITTO20110638A1 (it) | 2012-01-22 |
| JP2013533269A (ja) | 2013-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2496800A (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition | |
| BR112012001297A2 (pt) | conector. | |
| AU2018253544A1 (en) | Methods for treating or preventing asthma by administering an IL-4R antagonist | |
| PH12013500108A1 (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| EA201591269A1 (ru) | Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта | |
| PH12018500960A1 (en) | Processes for preparing isoquinolinones and solid forms of isoquinolinones | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| MX2014002395A (es) | Inhibidores de rock suaves, novedosos. | |
| HK1208231A1 (en) | Treatment for rheumatoid arthritis | |
| EA201290603A1 (ru) | Способ лечения | |
| EA201400623A1 (ru) | Новые 2h-индазолы в качестве антагонистов рецептора ep | |
| SG10201807318RA (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab | |
| GB2496795A (en) | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system | |
| WO2011060253A3 (en) | Methods of treating diseases, pharmaceutical compositions, and pharmaceutical dosage forms | |
| EA201500765A1 (ru) | Способы лечения сердечно-сосудистых заболеваний | |
| WO2013153349A3 (en) | Pharmaceutical composition comprising arformoterol and fluticasone furoate | |
| UA89921C2 (ru) | Способ лечения хронического обструктивного заболевания лёгких при помощи месалазина | |
| UA55818U (ru) | Способ лечения хронических заболеваний роговицы | |
| MX2012014799A (es) | Composición medicinal, método de preparación y uso de la misma. | |
| MX2019009243A (es) | Antagonistas il-4r para usarse en el tratamiento o previncion de asma persistente y asma severa. | |
| EA201991113A1 (ru) | Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта | |
| MY169877A (en) | Treatment of malphigia coccigera on liver cirrhosis | |
| UA59177U (ru) | Способ лечения больных с синдромом повышенной усталости, соединенным с хронической патологией гепатобилиарной системы | |
| TH171834A (th) | การปฏิบัติต่อโรคระบบทางเดินหายใจ | |
| UA59658U (ru) | Способ лечения больных с синдромом повышенной усталости на фоне хронической патологии гепатобилиарной системы |